Barinthus Biotherapeutics plc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation United Kingdom
Business Address 20400 CENTURY BLVD, GERMANTOWN, MD, 20874
Mailing Address 20400 CENTURY BLVD, GERMANTOWN, MD, 20874
Phone 44 (0) 1865 818808
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K Current report of material events | December 10, 2025 | View on SEC |
| 8-K Current report of material events | November 7, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| 8-K Current report of material events | September 30, 2025 | View on SEC |
| 8-K/A Current report amendment | August 8, 2025 | View on SEC |
| 8-K Current report of material events | August 7, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 7, 2025 | View on SEC |
| 4 Insider stock transaction report | June 11, 2025 | View on SEC |
| 4 Insider stock transaction report | June 11, 2025 | View on SEC |
Material Events
8-K Financial Distress January 6, 2026
High Impact
- Barinthus Biotherapeutics received a Nasdaq warning letter for failing to maintain a minimum $1.00 stock price for 30 consecutive business days.
- This places the company at risk of delisting from the Nasdaq Global Market.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.